Search results
Monitoring Abbvie Inc (ABBV) after recent insider movements – Knox Daily
Knox Daily· 1 day agoAbbvie Inc’s filing revealed that its EVP, CHIEF BUS/STRAT OFFICER Donoghoe Nicholas unloaded Company’s shares for reported $3.72 million on Mar 20 ’24.
AbbVie Inc. (NYSE:ABBV) to Post Q2 2024 Earnings of $3.01 Per Share, Zacks Research Forecasts
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Free Report) – Analysts at Zacks Research lifted their Q2 2024 earnings estimates for shares of AbbVie in a research report issued ...
Abbvie Inc (NYSE: ABBV) Jumps 1.36%: What Could Be On The Way Going Forward? – Stocks Register
Stocks Register· 5 days agoAbbvie Inc (NYSE:ABBV) shares, rose in value on Wednesday, May 15, with the stock price up by 1.36% to the previous day’s close as strong demand from buyers ...
Unlocking Intrinsic Value: Analysis of AbbVie Inc
GuruFocus.com via Yahoo Finance· 7 days agoIn this article, we will take a look into AbbVie Inc's (NYSE:ABBV) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value.
AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
Zacks via Yahoo Finance· 7 days agoAbbVie Inc. ABBV announced that it has signed a collaboration and option-to-license agreement with...
ABBV Stock Sees Surge of Approximately 2.08% in Last Five Days – Knox Daily
Knox Daily· 5 days agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Abbvie Inc shares valued at $3,716,757 were sold by ...
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
Zacks via Yahoo Finance· 7 days agoAbbVie (ABBV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good...
AbbVie shares hold Buy rating with $180 target from TD Cowen By Investing.com
Investing.com· 7 days agoOn Tuesday, TD (TSX:TD) Cowen maintained a positive stance on AbbVie Inc . TD Cowen adjusted its...
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst - AbbVie...
Benzinga· 4 days agoCantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target....
Earnings call: AbbVie projects robust growth and diversified pipeline By Investing.com
Investing.com· 5 days agoWith a growth platform that accounts for 80% of AbbVie's business, the company saw mid-teens growth...